FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:768-769 February 21, 2008 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Editor's Note: On February 15, 2008, after this article had gone to press, the Office for Human Research Protections (OHRP) issued a statement (www.hhs.gov/ohrp/news/recentnews.html#20080215) expressing its new conclusion that Michigan hospitals may continue to implement the checklist developed by Pronovost et al. "without falling under regulations governing human subjects research," since it "is now being used . . . solely for clinical purposes, not medical research or experimentation." OHRP further stated that in the research phase, the project "would likely have been eligible for both expedited IRB review and a waiver of the informed consent requirement."

About 80,000 catheter-related bloodstream . . . [Full Text of this Article]

Source Information

Dr. Baily is an associate for ethics and health policy at the Hastings Center, Garrison, NY.

This article has been cited by other articles:

• Bevan, J. C. (2008). Consent in the crossfire/Le consentement au c{oelig}ur du debat. Canadian J. Anesthesia 55: 495-500 [Full Text]  
• Nelson, R. B. (2008). Benefits and Drawbacks of Universal Surveillance of Methicillin-Resistant Staphylococcus aureus. ANN INTERN MED 149: 67-68 [Full Text]